Literature DB >> 29452670

What is the optimal management of older CLL patients?

Jennifer A Woyach1.   

Abstract

CLL is the most common leukemia in older adults with a median age at diagnosis of 71. Therefore, management of patients with this disease must take into account the older age of most patients and consequences of this in terms of functional status and organ function. This review will discuss the management of CLL with regards to observation prior to the initiation of therapy, functional status, and initial treatment. We will discuss criteria for the initiation of therapy, and how initial therapy is different between older and younger patients. Finally, we will discuss specific therapies including chemoimmunotherapy and newer targeted therapies that are being used widely in the older patient population.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic lymphocytic leukemia; Elderly; Geriatric assessment; Targeted therapies

Mesh:

Year:  2017        PMID: 29452670     DOI: 10.1016/j.beha.2017.10.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  3 in total

Review 1.  Inhibiting Bruton's Tyrosine Kinase in CLL and Other B-Cell Malignancies.

Authors:  Fabienne Lucas; Jennifer A Woyach
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

2.  Cyclosporine A therapy of chronic lymphoblastic leukemia-related pancytopenia: A case report.

Authors:  Mengying Wang; Ruoyu Meng; Yan Gao; Junxia Huang; Tianlan Li; Chunxia Mao; Shanshan Liu; Yujie Xu; Han Xu; Xianqi Feng
Journal:  Clin Case Rep       Date:  2022-03-10

Review 3.  Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?

Authors:  Moritz Fürstenau; Nisha De Silva; Barbara Eichhorst; Michael Hallek
Journal:  Hemasphere       Date:  2019-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.